Are we overregulated?
作者信息
Somberg J C
出版信息
Am J Ther. 2001 Jan-Feb;8(1):1-2. doi: 10.1097/00045391-200101000-00001.
Abstract
摘要
相似文献
1
Are we overregulated?
Am J Ther. 2001 Jan-Feb;8(1):1-2. doi: 10.1097/00045391-200101000-00001.
2
FDA mulls over paperless labeling.
Am J Health Syst Pharm. 2007 Jun 1;64(11):1120, 1122. doi: 10.2146/news070049.
3
The learned intermediary doctrine: past, present and future.
Leg Med. 1994:269-80.
4
Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
Food Drug Law J. 2006;61(4):585-622.
5
FDA's regulation of prescription drug labeling: a role for implied preemption.
Food Drug Law J. 2007;62(1):227-47.
6
Tort claims and federal regulation of medical devices vs pharmaceuticals.
JAMA. 2009 Sep 16;302(11):1169; author reply 1169-70. doi: 10.1001/jama.2009.1333.
7
PLIVA v. Mensing: generic consumers' unfortunate hand.
Yale J Health Policy Law Ethics. 2012 Summer;12(2):209-63.
8
Congress, the FDA, and the fair development of new medications for children.
Pediatrics. 2003 Sep;112(3 Pt 1):669-70. doi: 10.1542/peds.112.3.669.
9
To inform or persuade? Direct-to-consumer advertising of prescription drugs.
N Engl J Med. 2005 Jan 27;352(4):325-8. doi: 10.1056/NEJMp048357.
10
Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Food Drug Law J. 2007;62(4):653-94.
Zotero 插件